Mineralys Therapeutics, Inc.
US ˙ NasdaqGS ˙ US6031701013

SecurityMLYS / Mineralys Therapeutics, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership600,041 shares
Latest Disclosed Value $ 16,255,111
Citadel Advisors Llc ownership in MLYS / Mineralys Therapeutics, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 600,041 shares of Mineralys Therapeutics, Inc. (US:MLYS) valued at $16,255,111 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 399,919 shares of Mineralys Therapeutics, Inc.. This represents a change in shares of 50.04% during the quarter. The current value of the position is $14,214,971 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (MLYS) in the form of stock options. The firm currently holds call options representing 89,500 of underlying shares valued at $2,424,555 USD and put options representing 73,600 of underlying shares valued at $1,993,824 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MLYS / Mineralys Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F MINERALYS THERAPEUTICS COM 603170101 600,041 200,122 50.04 16,255 12.00 0.0023
2026-02-17 2025-12-31 13F MINERALYS THERAPEUTICS COM 603170101 399,919 -1,667,308 -80.65 14,513 -81.49 0.0022
2025-11-14 2025-09-30 13F MINERALYS THERAPEUTICS COM 603170101 2,067,227 2,052,845 14,273.71 78,389 40,306.70 0.0119
2025-08-14 2025-06-30 13F MINERALYS THERAPEUTICS COM 603170101 14,382 -129,980 -90.04 195 -91.54 0.0000
2025-05-15 2025-03-31 13F MINERALYS THERAPEUTICS COM 603170101 144,362 144,362 2,292 0.0004
2025-02-14 2024-12-31 13F MINERALYS THERAPEUTICS COM 603170101 0 -3,136 -100.00 0 -100.00
2024-11-14 2024-09-30 13F MINERALYS THERAPEUTICS COM 603170101 3,136 -9,898 -75.94 38 -75.66 0.0000
2024-08-14 2024-06-30 13F MINERALYS THERAPEUTICS COM 603170101 13,034 12,937 13,337.11 152 15,100.00 0.0000
2024-05-15 2024-03-31 13F MINERALYS THERAPEUTICS COM 603170101 97 -115,206 -99.92 1 -99.90 0.0000
2024-02-14 2023-12-31 13F MINERALYS THERAPEUTICS COM 603170101 115,303 96,687 519.38 992 459.89 0.0002
2023-11-14 2023-09-30 13F MINERALYS THERAPEUTICS COM 603170101 18,616 18,616 177 0.0000
2023-08-14 2023-06-30 13F MINERALYS THERAPEUTICS COM 603170101 0 -191,048 -100.00 0 -100.00
2023-05-15 2023-03-31 13F MINERALYS THERAPEUTICS COM 603170101 191,048 191,048 2,992 0.0007
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F MINERALYS THERAPEUTICS COM Call 89,500 50.17 2,425 12.12 n/a n/a n/a
2026-02-17 2025-12-31 13F MINERALYS THERAPEUTICS COM Call 59,600 87.42 2,163 79.42 n/a n/a n/a
2025-11-14 2025-09-30 13F MINERALYS THERAPEUTICS COM Call 31,800 1,206 n/a n/a n/a
2025-08-14 2025-06-30 13F MINERALYS THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F MINERALYS THERAPEUTICS COM Call 9,100 145 n/a n/a n/a
2025-02-14 2024-12-31 13F MINERALYS THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F MINERALYS THERAPEUTICS COM Call 8,300 -51.18 101 -49.49 n/a n/a n/a
2024-08-14 2024-06-30 13F MINERALYS THERAPEUTICS COM Call 17,000 70.00 199 53.49 n/a n/a n/a
2024-05-15 2024-03-31 13F MINERALYS THERAPEUTICS COM Call 10,000 1,900.00 129 3,125.00 n/a n/a n/a
2024-02-14 2023-12-31 13F MINERALYS THERAPEUTICS COM Call 500 4 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F MINERALYS THERAPEUTICS COM Put 73,600 109.09 1,994 56.07 n/a n/a n/a
2026-02-17 2025-12-31 13F MINERALYS THERAPEUTICS COM Put 35,200 -32.18 1,277 -35.11 n/a n/a n/a
2025-11-14 2025-09-30 13F MINERALYS THERAPEUTICS COM Put 51,900 1,968 n/a n/a n/a
2025-08-14 2025-06-30 13F MINERALYS THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F MINERALYS THERAPEUTICS COM Put 52,200 829 n/a n/a n/a
2025-02-14 2024-12-31 13F MINERALYS THERAPEUTICS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F MINERALYS THERAPEUTICS COM Put 4,800 200.00 58 222.22 n/a n/a n/a
2024-08-14 2024-06-30 13F MINERALYS THERAPEUTICS COM Put 1,600 -74.60 19 -77.78 n/a n/a n/a
2024-05-15 2024-03-31 13F MINERALYS THERAPEUTICS COM Put 6,300 81 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.